# Anti-Inflammatory Effects of Pioglitazone

> **NCT00722631** · NA · COMPLETED · sponsor: **Kurume University** · enrollment: 70 (actual)

## Conditions studied

- Impaired Glucose Tolerance
- Type 2 Diabetes Mellitus
- Atherosclerosis

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Glimepiride

## Key facts

- **NCT ID:** NCT00722631
- **Lead sponsor:** Kurume University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2009-04
- **Final completion:** 2012-04
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2012-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00722631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00722631, "Anti-Inflammatory Effects of Pioglitazone". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00722631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*